Taiwan's PuriBlood Medical (6847.TWO) has officially entered the largest market in South America—Brazil! The company recently signed a groundbreaking clinical trial and distribution agreement with ABHH (the Brazilian Association of Hematology, Hemotherapy, and Cell Therapy) and major medical importer Cromo (Comercio and Distribuicao de Materiais Odonto-Medico Hospitlares Ltda).
 
As Taiwan’s only developer of leukocyte filters and blood bags, PuriBlood boasts unique technical advantages. Backed by Formosa Plastics Group (holding a 10% stake) and leveraging manufacturing support from Nan Ya Plastics, the company’s cutting-edge technology is setting new standards in blood filtration.
 
President and CEO Dr. Luke Chen emphasized that this partnership is not just a milestone for Brazil but a strategic foundation for expansion into European and American markets.
 
Stay tuned for updates on this innovative leap in biotech!
Follow #Globalbio for the latest news in medical technology.
#BiotechBreakthrough #BloodFiltration #TaiwanInnovation #BrazilExpansion